Federal officials are reminding everyone that even while they review the J&J vaccine for six reports of a rare blood clot disorder, there are two safe and effective vaccines in wide distribution now.
LAUREN PASTRANA: Getting back to the coronaviruses pandemic, with the federal government putting a pause on the Johnson & Johnson COVID vaccine, there is growing concern that it's making people think twice about getting vaccinated. But health experts want to remind everyone that, even while they review the J&J vaccine over the rare blood clot disorder, there are two safe and effective vaccines in wide distribution right now. CBS 4's Nancy Chen reports.
NANCY CHEN: With the pause in the Johnson & Johnson vaccine, health experts stress tens of millions of Americans have already safely received the Pfizer and Moderna vaccines.
TARA NARULA: Certainly, Americans should feel reassured that, at least with those vaccines that are readily available now, that there should not be any incidents-- we haven't seen any-- of this particular rare condition.
NANCY CHEN: CBS News senior medical correspondent, Dr. Tara Narula, hopes that everyone who can be vaccinated will still have confidence and get the shot.
TARA NARULA: We really do need people to take the vaccines if they can, the ones that are available that we know are safe and effective.
NANCY CHEN: Experts stress that these types of pauses are actually normal in the rollout of a vaccine or new drug. And health officials don't want that hiccup to slow down the vaccination effort.
VIVEK MURTHY: People need to know that the system is working for them, and we're being vigilant
NANCY CHEN: Dr. Ross Kedl has been studying vaccines for a quarter of a century. He's hoping people will still trust vaccinations, because it's critical to end this pandemic.
ROSS KEDL: It's infinitely safer to be taking one of these vaccines than it is to be running the risk of coronavirus infection.
NANCY CHEN: The government expects this pause in the Johnson & Johnson vaccine to last just a few days to a week. Nancy Chen, CBS News, New York.